Comments by J. C. Spencer

For years I have contended that autism and neurodevelopmental disorders are a result of vaccines containing mercury. Our Nutritional Pilot Surveys using plant sugars have caused us to believe that glycomics holds a potential answer to this health challenge. Go to the NEWS section on the Home Page of The Endowment for Medical Research at www.endowmentmed.org/ and click on Autism for some of my previous newsletters dealing with the subject.

Today the US Autism & Asperger Association announced that hidden CDC data confirms the vaccine link.

Here is the News Release, the Abstract and the Link to the complete hidden paper.

WASHINGTON, DC . A newly published study in the Journal of the Neurological Sciences,[1] the official journal of the World Federation of Neurology,[2] links mercury from the Thimerosal in vaccines with autism and other neurodevelopmental disorders. This study represents six years worth of effort by independent researchers to gain access to hidden US Centers for Disease Control and Prevention data in the Vaccine Safety Datalink.

In 2003, the Government Reform Committee of the US House of Representatives asserted, access by independent researchers to the Vaccine Safety Datalink database is needed for independent replication and validation of CDC studies regarding exposure of infants to mercury-containing vaccines and autism.

Nonetheless, this new analysis of some of the data in the carefully guarded VSD database, documenting the mercury poisoning of a generation of American children, would never have been possible without the intervention of Congressional leaders, parent autism advocacy groups, and legal experts. Ironically, only a few independent researchers have gained even this limited level of restricted access to the VSD database, despite the fact that the VSD Project is funded by hundreds of millions of taxpayer dollars.

The new study, led by Dr. Heather Young, Ph.D., a professor of epidemiology at the George Washington University School of Public Health and Health Services, examined the CDC-supplied medical vaccination records from the VSD of 278,624 children, born from 1990 through 1996.

This study calculated the average mercury exposure children incurred from routine childhood Thimerosal-containing vaccines, by year of birth, during their first year of life. After calculating average mercury exposure by year of birth, the study then estimated the prevalence rates of various medical diagnoses for children born in each of the years examined.

The prevalence rate of autism and other neurodevelopmental disorders correlated with the average mercury exposure children received: increasing/decreasing levels of mercury exposure from routine childhood Thimerosal-containing vaccines resulted in corresponding trends in prevalence rates of these diagnoses. By contrast, medical outcomes presumed to be unrelated to mercury exposure did not correlate with the average levels of mercury exposure from routine childhood Thimerosal-containing vaccines.

Depending upon the specific neurodevelopmental disorder examined (autism, autism spectrum disorder, tics, emotional disturbance, attention deficit disorder-hyperactivity disorder, and developmental/learning disorder), the observed overall risk of autism and other neurodevelopmental disorders was significantly higher (about 2- to 6- fold) following an additional 100 micrograms of mercury exposure. For autism alone, the overall risk was about 2.5-fold higher following an additional 100 micrograms of mercury exposure.

These results demonstrate that the suspicions of those serving on the Government Reform Committee were correct: ..(t)o date, studies conducted or funded by the CDC that purportedly dispute any correlation between autism and vaccine injury have been of poor design, under-powered, and fatally flawed. The CDC�s rush to support and promote such research is reflective of a philosophical conflict in looking fairly at emerging theories and clinical data related to adverse reactions from vaccinations.

To financially support further research conducted by independent investigators in the VSD, please use the PayPal link on CoMeD�s website, http://www.mercuryfreedrugs.org/ for your tax-deductible contributions. CoMeD, Inc. is a not-for-profit 501(C)(3) corporation actively engaged in legal, educational and scientific efforts to stop all use of mercury in medicine, and to ban the use of all mercury-containing medicines.

[1] Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci. 2008 May 1 4. [Epub ahead of print] Article available at: http://www.pharmalot.com/wpcontent/uploads/2008/05/thimerosalvaccinestudy.pdf

[2] The World Federation of Neurology is a non-governmental organization associated with the World Health Organization (WHO).

Abstract:

Thimerosal exposure in infants and neurodevelopmental disorders:

An assessment of computerized medical records in the Vaccine Safety Datalink

Heather A. Young a, David A. Geier b, Mark R. Geier c,.

a The George Washington University School of Public Health and Health Services, Department of Epidemiology and Biostatistics, United States

b The Institute of Chronic Illnesses, Inc., Silver Spring, MD 20905, United States

c The Genetic Centers of America, United States

Received 20 December 2007; received in revised form 27 March 2008; accepted 1 April 2008

Abstract

The study evaluated possible associations between neurodevelopmental disorders (NDs) and exposure to mercury (Hg) from Thimerosalcontaining vaccines (TCVs) by examining the automated Vaccine Safety Datalink (VSD). A total of 278,624 subjects were identified in birth cohorts from 1990 - 1996 that had received their first oral polio vaccination by 3 months of age in the VSD. The birth cohort prevalence rate of medically diagnosed International Classification of Disease, 9th revision (ICD-9) specific NDs and control outcomes were calculated.

Exposures to Hg from TCVs were calculated by birth cohort for specific exposure windows from birth-7 months and birth-13 months of age.

Poisson regression analysis was used to model the association between the prevalence of outcomes and Hg doses from TCVs. Consistent significantly increased rate ratios were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with Hg exposure from TCVs. By contrast, none of the control outcomes had significantly increased rate ratios with Hg exposure from TCVs. Routine childhood vaccination should be continued to help reduce the morbidity and mortality associated with infectious diseases, but efforts should be undertaken to remove Hg from vaccines. Additional studies should be conducted to further evaluate the relationship between Hg exposure and Nds.

Press Release Contacts:
For Immediate Release CoMeD President [Rev. Lisa K. Sykes (Richmond, VA)
804-364-8426]
June 12, 2008 CoMeD Sci. Advisor [Dr. King (Lake Hiawatha, NJ)
973-263-4843]

� 2008 Elsevier B.V. All rights reserved.
Keywords: ADD; ADHD autistic disorder; ASD; Ethylmercury; Merthiolate; Thiomersal

For the complete paper:

http://www.pharmalot.com/wp-content/uploads/2008/05/thimerosal-vaccine-study.pdf